<DOC>
	<DOCNO>NCT02831504</DOCNO>
	<brief_summary>PhenoDM1 use patient report outcome assess level pain , fatigue quality life cohort . Clinical functional outcome look muscle wasting level myotonia . DNA , RNA , serum CSF sample take patient additional genetic molecular biomarker analysis carry . A subset patient undergo detailed sleep study along skeletal muscle MRI low limb . This study complement work group currently look myotonic dystrophy type 1 use outcome measure possible .</brief_summary>
	<brief_title>PhenoDM1 ( Myotonic Dystrophy Type 1 Natural History Study )</brief_title>
	<detailed_description>Myotonic Dystrophy type I ( DM1 ) common form adult muscular dystrophy , affect 1 8000 individual . It autosomal dominant disorder multisystemic involvement multiple organ tissue , namely brain , heart , endocrine system , eye smooth skeletal muscle . It result CTG expansion untranslated region 3 ' terminal DMPK gene cause disturbance RNA metabolism , particular defective splice various pre-mRNAs muscular chloride channel ( cause myotonia ) , insulin receptor ( cause diabetes ) others . We carry in-depth characterisation 400 adult DM1 patient identify local clinical population across England national DM Registry . Over two year period take measurement 12 month apart address specific symptom cause major quality life impairment include muscle weakness , myotonia , excessive daytime sleepiness cognitive impairment . DNA sample collect order determine CTG repeat length serum sample biomarker identification . We carry muscle MRI sleep study subset 50 patient . The implemented measure capitalise effort previous cohort study ensure measure comparable exist datasets .</detailed_description>
	<mesh_term>Myotonic Dystrophy</mesh_term>
	<criteria>Main Inclusion Criteria 1 . 18 year age 2 . Genetic confirmation Myotonic Dystrophy Type 1 3 . Able consent willing participate throughout duration study . Additional Inclusion Criteria MRI study : 1 . Aged 18 55 year 2 . Ambulant ambulantassisted Additional Inclusion Criteria sleep study : 1 . Aged 18 55 year Main Exclusion Criteria 1 . Inability give inform consent 2 . If clinician presumes patient able perform motor function test involve ( Six Minute Walk Test , 30 Seconds Sit Stand Test , Timed 10Meter Walk Test ) 3 . Inability perform cardiac pulmonary assessment Additional Exclusion Criteria MRI study : 1 . Pacemaker , ICD nonMRIcompatible prosthetic material . Additional Exclusion Criteria sleep study : 1. ventilate patient 2. patient medicated stimulant , include Modafinil 3. patient medicate benzodiazepine antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Myotonic Dystrophy type 1</keyword>
	<keyword>DM1</keyword>
	<keyword>Muscular Dystrophy</keyword>
	<keyword>Neuromuscular Diseases</keyword>
</DOC>